|
Market Closed -
OTC Markets
10:25:24 2021-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.5000 USD | +66.67% |
|
+166,566.67% | +166,566.67% |
| 17-11-28 | Optigenex Inc. announced that it has received $0.63 million in funding | CI |
| 17-11-06 | Optigenex Inc. announced a financing transaction | CI |
| Market Cap | 19.94K 17.72K 16.42K 14.94K 28.2K 1.89M 28.65K 197K 77.41K 987K 74.82K 73.22K 3.15M | P/E 2006 * |
-
| P/E 2007 | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.95M 7.96M 7.38M 6.71M 12.67M 850M 12.87M 88.67M 34.77M 443M 33.6M 32.89M 1.41B | EV / Sales 2006 |
20.5x | EV / Sales 2007 | 19.3x |
| Free-Float |
21.27% | Yield 2006 * |
-
| Yield 2007 | - |
| 1 day | +66.67% | ||
| 1 week | +166,566.67% | ||
| Current month | +166,566.67% | ||
| 1 month | +166,566.67% | ||
| 3 months | +166,566.67% | ||
| 6 months | +166,566.67% | ||
| Current year | +166,566.67% |
| 1 week | 0 | 0.5 | |
| 1 month | 0 | 0.5 | |
| Current year | 0 | 0.5 | |
| 1 year | 0 | 0.5 | |
| 3 years | 0 | 0.5 | |
| 5 years | 0 | 1 | |
| 10 years | 0 | 3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 69 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +66.67% | +166,566.67% | +1,140.69% | -50.00% | 35 | ||
| +0.43% | +6.59% | +53.41% | +103.85% | 1,120B | ||
| +0.90% | -2.25% | +33.02% | +62.23% | 616B | ||
| +0.71% | +3.24% | +25.81% | +93.86% | 504B | ||
| -0.13% | +5.98% | +32.91% | +50.39% | 367B | ||
| +0.52% | +0.24% | +73.92% | +40.15% | 360B | ||
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | ||
| -1.98% | +3.73% | -0.86% | +13.43% | 258B | ||
| -0.35% | +4.25% | +46.21% | +50.76% | 234B | ||
| -0.75% | +3.32% | +32.53% | +97.21% | 194B | ||
| Average | +6.51% | +3.25% | +145.72% | +50.49% | 394.09B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.18% | +71.44% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 301K 267K 248K 226K 426K 28.56M 432K 2.98M 1.17M 14.9M 1.13M 1.11M 47.51M | 466K 414K 384K 349K 659K 44.22M 670K 4.61M 1.81M 23.08M 1.75M 1.71M 73.57M |
| Net income | -7.36M -6.54M -6.06M -5.52M -10.41M -698M -10.57M -72.86M -28.57M -364M -27.61M -27.02M -1.16B | -2.9M -2.58M -2.39M -2.17M -4.1M -275M -4.16M -28.7M -11.25M -144M -10.88M -10.64M -458M |
| Net Debt | 6M 5.33M 4.94M 4.5M 8.49M 569M 8.62M 59.41M 23.29M 297M 22.51M 22.03M 947M | 8.93M 7.94M 7.36M 6.7M 12.64M 848M 12.84M 88.48M 34.69M 442M 33.53M 32.82M 1.41B |
Employees
1
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | US$0.000300 | -.--% | 900 |
- Stock Market
- Stocks
- OPGX Stock
Select your edition
All financial news and data tailored to specific country editions
















